![jama glp-1 Glucagon-like peptide-1 (GLP-1) receptor agonists (semaglutide [Wegovy, Ozempic, Rybelsus]) and dual incretin agonists (tirzepatide [Zepbound, Mounjaro]) are medications that reduce food cravings, increase fullness, slow digestion, and can help control From JAMA: #GLP-1 receptor agonist](https://lookaside.instagram.com/seo/google_widget/crawler/?media_id=3678716518672074937)
jama glp-1 Glucagon-like peptide-1 (GLP-1) receptor agonists (semaglutide [Wegovy, Ozempic, Rybelsus]) and dual incretin agonists (tirzepatide [Zepbound, Mounjaro]) are medications that reduce food cravings, increase fullness, slow digestion, and can help control From JAMA: #GLP-1 receptor agonist
Description
Data are presented as medians (interquartile ranges) or frequencies (%), and Wilcoxon signed-rank tests and Mann-Whitney U tests were used for paired and nonpaired group comparisons, respectively
![jama glp-1 Glucagon-like peptide-1 (GLP-1) receptor agonists (semaglutide [Wegovy, Ozempic, Rybelsus]) and dual incretin agonists (tirzepatide [Zepbound, Mounjaro]) are medications that reduce food cravings, increase fullness, slow digestion, and can help control From JAMA: #GLP-1 receptor agonist](https://lookaside.fbsbx.com/lookaside/crawler/media/?media_id=1252551870252431)
Learn more about heartburn, bloating, nutrition, and other common challenges for GLP-1 patients and how Haleons wellness solutions can support.
![jama glp-1 Glucagon-like peptide-1 (GLP-1) receptor agonists (semaglutide [Wegovy, Ozempic, Rybelsus]) and dual incretin agonists (tirzepatide [Zepbound, Mounjaro]) are medications that reduce food cravings, increase fullness, slow digestion, and can help control From JAMA: #GLP-1 receptor agonist](https://lookaside.fbsbx.com/lookaside/crawler/media/?media_id=1179471587560460)
Health Benefits
![jama glp-1 Glucagon-like peptide-1 (GLP-1) receptor agonists (semaglutide [Wegovy, Ozempic, Rybelsus]) and dual incretin agonists (tirzepatide [Zepbound, Mounjaro]) are medications that reduce food cravings, increase fullness, slow digestion, and can help control From JAMA: #GLP-1 receptor agonist](https://pbs.twimg.com/media/HHlCAZuW4AYAkYZ.jpg)
Take 1 capsule daily, preferably 1530 minutes before a meal or as directed by your healthcare professional
![jama glp-1 Glucagon-like peptide-1 (GLP-1) receptor agonists (semaglutide [Wegovy, Ozempic, Rybelsus]) and dual incretin agonists (tirzepatide [Zepbound, Mounjaro]) are medications that reduce food cravings, increase fullness, slow digestion, and can help control From JAMA: #GLP-1 receptor agonist](https://pbs.twimg.com/media/GwdPVXIXsAAkqM0.jpg)
It replenishes moisture and helps return that healthy, radiant glow
![jama glp-1 Glucagon-like peptide-1 (GLP-1) receptor agonists (semaglutide [Wegovy, Ozempic, Rybelsus]) and dual incretin agonists (tirzepatide [Zepbound, Mounjaro]) are medications that reduce food cravings, increase fullness, slow digestion, and can help control From JAMA: #GLP-1 receptor agonist](https://lookaside.fbsbx.com/lookaside/crawler/media/?media_id=1423114089862874)
This shift is not just about the numbersits changing how physicians and patients think about managing T2D and its many related comorbidities
![jama glp-1 Glucagon-like peptide-1 (GLP-1) receptor agonists (semaglutide [Wegovy, Ozempic, Rybelsus]) and dual incretin agonists (tirzepatide [Zepbound, Mounjaro]) are medications that reduce food cravings, increase fullness, slow digestion, and can help control From JAMA: #GLP-1 receptor agonist](https://lookaside.instagram.com/seo/google_widget/crawler/?media_id=3448932409653062348)
